Maria Arechiga, an Intensive Care Unit (ICU) Charge Nurse, checks on an intubated COVID-19 patient in the ICU of Martin Luther King Jr. Community Hospital on Friday Jan. 15, 2021. The floor was converted to an ICU unit the week before to help with the surplus of COVID-19 patients.
Gabriella Angotti-Jones for NPR
Gabriella Angotti-Jones for NPR
Maria Arechiga, an Intensive Care Unit (ICU) Charge Nurse, checks on an intubated COVID-19 patient in the ICU of Martin Luther King Jr. Community Hospital on Friday Jan. 15, 2021. The floor was converted to an ICU unit the week before to help with the surplus of COVID-19 patients.
Airdate: Thursday, April 8, 2021
Soon after former President Donald Trump tested positive for the COVID-19 virus, he received and credited a little-known antibody treatment for making him feel better almost immediately.
In 2020, the FDA authorized the treatment for emergency use and UPMC began offering Monoclonal antibody infusions to eligible patients with significant results.
Dr. Richard Wadas, M.D., Emergency Medicine Physician and co-lead of UPMC monoclonal antibody efforts appears on Smart Talk Thursday to discuss eligibility and efficacy of the treatment.
Smart Talk is also joined by Dr. John Goldman, M.D., Infectious Disease specialist, with UPMC to offer insight to other COVID issues and treatments, and will answer vaccine questions.
For more information on Monoclonal Antibody treatment call the UPMC Pinnacle Nurse Advice team at 1-866-9-NURSE1 (1-866-968-7731) or 717-988-T0074.
